Skip to content
Due to a shortage of funding, the U.S. government expects to “wind down” procuring and dispensing COVID-19 vaccines as early as January. Americans will […]
Americans could be charged for COVID-19 vaccines as early as January Read More »
In its efforts to fight the current opioid crisis, the Food and Drug Administration (FDA) published on Tuesday its Overdose Prevention Framework. The Framework
FDA to tackle overdose crisis with Overdose Prevention Framework Read More »
The U.S. will soon have enough monkeypox vaccine available “for everyone in the at-risk community to receive two doses of vaccine,” said White House
White House: U.S. will soon have enough monkeypox vaccine for everyone at risk Read More »
The US Food and Drug Administration (FDA) is “close to authorizing updated doses that would target the versions of the virus now circulating,” Dr.
Biden administration to offer updated jabs in fall booster campaign Read More »
In an opinion piece for Agri-Pulse, Biotechnology Innovation Organization (BIO) President and CEO Dr. Michelle McMurry-Health argued that “FDA’s recent efforts to develop a
BIO CEO: Regulatory certainty needed to encourage food innovation Read More »
The practice of making drug makers give rebates to payers encourages Medicare Part D insurers to steer patients away from generic drugs that cost
HHS probe: Insurer PBMs pocket rebates as patients, taxpayers pay more Read More »
The U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Novavax COVID-19 vaccine Adjuvanted (NVX-CoV2373) “for the prevention of Coronavirus Disease
Novavax COVID vaccine granted EUA for adolescents ages 12 to 17 Read More »
The Inflation Reduction Act, passed August 7, 2022, will hit biotech innovation hard by enacting drug price controls on around 100 drugs over the
Who the Inflation Reduction Act helps Read More »
Faced with the surging number of monkeypox cases in the U.S, the White House announced new actions on Thursday to accelerate the distribution of
Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC), is urging reorganization of the agency, saying that the potential “reset”
Dr. Walensky urges CDC reorganization after COVID-19 response Read More »
